| answer text |
<p>The UK recognises the complex interdependencies between the health of people, animals,
plants and the natural environment, and the need to address threats holistically –
through a ‘One Health’ approach. There is close collaboration between animal and human
health sectors to prepare and respond to disease threats, for example through the
Human Animal Infections and Risk Surveillance (HAIRS) group (<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fgroups%2Fhuman-animal-infections-and-risk-surveillance-group&data=04%7C01%7CSRIHub%40beis.gov.uk%7C8d8afb11a1e54c2720b608d971fb1d55%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637666145623364748%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=bcVWUbeFfT3SREG8WK%2B4Dpp9tZL6LGKpzgGjcJJz30s%3D&reserved=0"
target="_blank">https://www.gov.uk/government/groups/human-animal-infections-and-risk-surveillance-group</a>).</p><p>
</p><p>The development and application of veterinary vaccines are a crucial instrument
in support of disease control and such R&D forms a fundamental part of our <a
href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fdefra-group-research-and-innovation-interests-2021%2Fdefra-group-research-and-innovation-interests&data=04%7C01%7CSRIHub%40beis.gov.uk%7C8d8afb11a1e54c2720b608d971fb1d55%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637666145623364748%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=gdVu5sD1hTgY9N3mXA8hn%2FYunml4eZmJsrOLipc7pXk%3D&reserved=0"
target="_blank">biosecurity research priorities</a>. Over the past five years, the
Biotechnology and Biological Sciences Research Council (BBSRC) has invested £177.2
million in veterinary vaccinology research and innovation including the Global Challenges
Research Fund Networks in Vaccine R&D call, led by the Medical Research Council
and supported by BBSRC, committing £9.6 million to support global, multisector research
communities tackle key challenges facing human and veterinary vaccine R&D. The
Networks foster and support an interdisciplinary One Health agenda through pump-prime
funding and networking and knowledge exchange activities. BBSRC and Defra also work
with European and International partners though Horizon 2020 programmes as well as
through a Global Coronavirus research and innovation network jointly funded by BBSRC
and Defra.</p><p> </p><p>In June investment was announced for a new <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.pirbright.ac.uk%2Fnews%2F2021%2F06%2Fnew-animal-vaccine-manufacturing-and-innovation-centre-be-established-pirbright&data=04%7C01%7CSRIHub%40beis.gov.uk%7C8d8afb11a1e54c2720b608d971fb1d55%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637666145623374698%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=Vu38WttMcZEi0WWMKhEadaCmwV4vHylG3LrH%2Bull%2Bgk%3D&reserved=0"
target="_blank">Animal Vaccine Manufacturing and Innovation Centre</a> to be established
at The Pirbright Institute (TPI), a strategically funded BBSRC institute, with contributions
from the Foreign, Commonwealth and Development Office and the Gates Foundation. The
Centre will develop and improve the use of veterinary vaccines for control of a number
of diseases, both in the UK and Developing Countries, and will enable improvements
to animal and public health directly and provide wider benefits including combating
antimicrobial resistance.</p><p> </p><p>The BBSRC Bioscience for Health Strategic
Framework also outlines One Health as a key strategic challenge area with a vision
of collaborative and coordinated approaches to combat zoonotic with a focus on prediction,
prevention, response and recovery principles to improve the health and wellbeing of
animals and people in their environments.</p>
|
|
